Returns | |
1 month return | 0.62% |
3 month return | 1.67% |
1 year return | 0.77% |
5 year return | 26.19% |
Organization | Quest Diagnostics, Inc. |
Employees | 47000 |
CEO | Stephen Rusckowski |
Industry | Health Services |
Current
$136.68
Target
$151.5
Current | 1M Ago | 3M Ago | |
Buy | 12 | 13 | 14 |
Hold | 11 | 9 | 8 |
Sell | 0 | 0 | 0 |
Consensus | BUY | BUY | BUY |
Market Capitalization | 16.1B |
Book Value | 54.15 |
Dividend Share | 2.48 |
Dividend Yield | 2.48 |
Earnings Share | 15.55 |
PE Ratio | 8.8412 |
PEG Ratio | 1.24 |
Wall Street Target Price | 151.71 |
Trailing PE | 8.84 |
Forward PE | 15.2 |
Price/Sales (ttm) | 1.5 |
Price/Book (mrq) | 2.52 |
Enterprise Value | 20.0B |
Enterprise Value/Revenue | 1.87 |
Enterprise Value/Ebitda | 6.69 |
Beta | 1.1 |
50 Day MA | 136.91 |
200 Day MA | 145.65 |
Rating Date | 2019-01-01 |
Total Esg | 18.33 |
Total Esg Percentile | 16.26 |
Environment Score | 0.86 |
Environment Score Percentile | 1.0 |
Social Score | 10.42 |
Social Score Percentile | 1.0 |
Governance Score | 5.77 |
GovernanceScorePercentile | 1.0 |
Controversy Level | 3.0 |